Angelalign TechnologyAGLFF -1.74%73 Interest Coverage is 62.23 as of Dec. 2025, which is 32% below its 10-year median of 91.02. GuruFocus rates AGLFF with a GF Score™ of 73/100 and a GF Value™ of $12.51 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 466 Medical Devices & Instruments companies, Angelalign Technology ranks better than 52.15% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Angelalign Technology's
Operating Income
for the
six
months ended in Dec. 2025 was $19.9 Mil. Angelalign Technology's Interest Expense for the
six
months ended in Dec. 2025 was $-0.3 Mil.
Angelalign Technology's interest coverage for the quarter that ended in Dec. 2025 was 62.23.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Angelalign Technology's Interest Coverage or its related term are showing as below:
AGLFF'
s Interest Coverage Range Over the Past 10 Years
Min: 18 Med: 91.02 Max: 245.89
Current: 18
AGLFF's Interest Coverage is ranked better than 52.15% of 466
companies
in the Medical Devices & Instruments industry
Industry Median: 15.875
vs AGLFF: 18.00
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Angelalign Technology Interest Coverage Related Terms
Angelalign Technology Interest Coverage Historical Data
* Premium members only.
The historical data trend for Angelalign Technology's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
AGLFF vs ISRG, BDX, MDLN: Interest Coverage Comparison
For the Medical Instruments & Supplies subindustry, Angelalign Technology's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Angelalign Technology Interest Coverage vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Angelalign Technology's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Angelalign Technology's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Angelalign Technology (AGLFF) has a Interest Coverage of 62.23 as of Dec. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Angelalign Technology and its competitors. This is 32% below median its historical median of 91.02. Over the past decade, Angelalign Technology's Interest Coverage has ranged from 18.00 to 245.89. According to the industry distribution chart, Angelalign Technology ranks #223 out of 466 companies in the Medical Devices & Instruments industry, placing it in the top 47.9%.
Is Angelalign Technology's Interest Coverage too high?
Angelalign Technology's current Interest Coverage of 62.23 is 32% below median its 10-year median of 91.02. Over the past 10 years, this metric has ranged from a low of 18.00 to a high of 245.89. The Medical Devices & Instruments industry median Interest Coverage is 15.88. Angelalign Technology's value of 62.23 is 292% above this industry median. Based on the distribution chart, Angelalign Technology ranks #223 out of 466 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Angelalign Technology has a GF Score™ of 73/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Angelalign Technology's Interest Coverage compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Angelalign Technology ranks #223 out of 466 companies for Interest Coverage. This puts Angelalign Technology in the upper half of its industry. The industry median Interest Coverage is 15.88. Angelalign Technology's value of 62.23 is 292% above this benchmark. Historically, Angelalign Technology's own Interest Coverage has ranged from 18.00 to 245.89 over the past decade. While the company's 10-year median is 91.02 vs. the industry median of 15.88, Angelalign Technology has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Devices & Instruments company?
The median Interest Coverage among Medical Devices & Instruments companies is 15.88, based on 466 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Angelalign Technology's current Interest Coverage of 62.23 is 292% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Angelalign Technology and its competitors. For the Medical Devices & Instruments industry, the median Interest Coverage is 15.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Angelalign Technology's current Interest Coverage is 62.23, which is 32% below median its own 10-year median of 91.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Angelalign Technology stock overvalued right now?
Based on GuruFocus' analysis, Angelalign Technology (AGLFF) is currently considered Significantly Undervalued. The stock's GF Value™ is $12.51, compared to a current price of $8.77 — trading 29.9% below its estimated fair value. The current Interest Coverage is 62.23, which is 32% below median its 10-year median of 91.02 and 292% above the Medical Devices & Instruments industry median of 15.88. Angelalign Technology's overall GF Score™ is 73/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Angelalign Technology (AGLFF), the current Interest Coverage is 62.23 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Angelalign Technology (AGLFF) Overvalued in 2026?
Based on GuruFocus' analysis, Angelalign Technology stock appears to be undervalued.
The current stock price of $8.77 is trading 29.9% below its estimated GF Value™ of $12.51.
GuruFocus considers Angelalign Technology to be Significantly Undervalued.
Key valuation signals for AGLFF:
Interest Coverage: 62.23 (32% below median its 10-year median of 91.02)
GF Value™: $12.51 vs. price of $8.77 (29.9% below fair value)
Industry Position: 292% above the Medical Devices & Instruments median (#223 of 466)
No single metric tells the full story. See the AGLFF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Angelalign Technology Inc is an investment holding company. It is principally engaged in clear aligner treatment solutions, including treatment planning services, manufacturing, and marketing of clear aligners. The company provides dental professionals with self-developed digital orthodontic solutions. The company's Angelalign clear aligner system facilitates dental professionals throughout the entire clear aligner treatment process, including digitally-assisted case assessment support and treatment planning services, provide dental professionals with digitally-assisted case assessment support and treatment planning services, and helps dental professionals design, review, and modify treatment plans.
73GF Score
Get the complete analysis for AGLFF
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AGLFF has been successfully added to your 
